Disposable Bronchoscope Market By Product Type (Rigid Bronchoscopes, Flexible Bronchoscopes, Adult Disposable Bronchoscopes, Pediatric Disposable Bronchoscopes, Neonatal Disposable Bronchoscopes), By Indication (Lung Cancer, Pulmonary Infections, Interstitial Lung Disease, Tuberculosis, COPD, Cystic Fibrosis, Other), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic and Speciality Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035

Industry Outlook

The Disposable Bronchoscope market accounted for USD 0.83 Billion in 2024 and is expected to reach USD 3.25 Billion by 2035, growing at a CAGR of around 13.2% between 2025 and 2035.  The disposable bronchoscope market is offering single-use bronchoscopes designed for diagnostic and therapeutic procedures within respiratory care. Unlike a reusable bronchoscope, a disposable bronchoscope does not pose the risk of cross-contamination and does not require the sterilizing process, creating an infection-prone, site-free device usable in intensive care, pulmonology, and surgery.

Increasing incidences of respiratory diseases, improvements in the bronchoscopy device, and the need for cheaper, cleaner products increase the demand for this market. They are also in greater demand in emergency departments due to their availability and preparedness. It is widely adopted in medical facilities that emphasize patient safety and infection control.

Report Scope:

Market Dynamics

Increasing Prevalence of Respiratory Diseases and Growing Demand for Minimally Invasive Procedures

The disposable bronchoscope market is highly fuelled by the rise of globally afflicted cases of respiratory diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, and pneumonia. COPD is ranked third among the causes of mortality by WHO. It is estimated that three million, two hundred and twenty-three individuals die from COPD every year, and more than 262 million people live with asthma globally. These diseases involve routine diagnosing and treating procedures in which bronchoscopes are central. This global trend also increases the need for disposable bronchoscopes in all healthcare sectors.

The rising need for disposable bronchoscopes is supported by the capacity to reduce cross-contamination, which remains a critical component of patient care even as the globe emerges from the COVID-19 pandemic. Some studies pointed out that utilizing reusable bronchoscopes increases the chances of hospital-acquired infection compared to disposable bronchoscopes. This has shifted the emphasis among healthcare providers to use single-use devices to improve patient safety.

Rising Awareness About Infection Control and Patient Safety in Healthcare Facilities

The most important driving factor for the disposable bronchoscope market is increased awareness regarding infection control and patient safety. Health facilities are adopting infection prevention measures by strictly implementing safety regulations and guidelines in their clinical practices. The use of disposable bronchoscopes helps prevent the risk of cross-contamination from one patient to another, an important factor, especially in a healthcare environment such as hospitals and clinics. Single-use devices are being invested in by healthcare providers to ensure there are high standards of hygiene maintained, especially with risky procedures like bronchoscopy.

For instance, this has been a global health initiative that focuses on patient safety and the reduction of infection in the clinical environment. This will reflect the importance of infection prevention, as disposable bronchoscopes offer a consistent, hygienic solution, which reduces reprocessing and sterilization needs and, therefore, the possibility of healthcare-associated infections. Increasing awareness is going to increase demand for disposable bronchoscopes across various healthcare facilities.

High Cost of Disposable Bronchoscopes Compared to Reusable Alternatives in Resource-Limited Settings

One of the most critical limitations in the disposable bronchoscope market is that the disposable version is significantly more expensive than the reusable one, especially in resource-poor environments. Even though disposable bronchoscopes have infection control benefits, they are not fiscally responsible for budget-sensitive healthcare facilities. Healthcare providers would often opt for cheaper alternatives and typically accept reusable bronchoscopes even if it increases the risk of cross-contamination unless there is a strong economic resource. Moreover, disposable devices are purchased as a continuous expense. The cost difference makes the technology not widely accepted, especially for small clinics and hospitals or rural health care centers. The providers in such resource-scarce environments would thus avoid or delay adopting the disposable bronchoscope technology, and therefore the growth in this market in those regions would be curbed. The affordability and availability of reusable alternatives continue to be a challenge to the uptake of disposable bronchoscopes.

Increasing Adoption in Ambulatory Surgical Centers and Emergency Care Units Globally

A huge opportunity for the growth of the disposable bronchoscope market is the increasing acceptance of disposable bronchoscopes in ambulatory surgical centers (ASCs) and emergency care units (ECUs). ASCs and ECUs are more focused on cost-effective, efficient, and safe diagnostic tools, whereas disposable bronchoscopes have different advantages. In such settings, they usually need fast, reliable procedures with minimum patient downtime, which makes disposable devices ideal for rapid diagnostics and interventions.

Disposable bronchoscopes appeal to fast-paced medical environments because of their ease of use and removal of reprocessing issues. Furthermore, with both ASCs and ECUs having a greater need for infection control, the disposable device offers no risk of cross-contamination. With these types of care facilities growing around the globe, disposable bronchoscopes will likely see increased usage, which will generate substantial market opportunities. Increased convenience and flexibility of disposable devices would further increase their usage in non-hospital settings, which could expand the scope of applications.

Growing Technological Advancements and Integration of Imaging Features in Disposable Devices

Technological advancements and integration of imaging features create a significant opportunity in the disposable bronchoscope market. The more the demand for high-quality, real-time imaging grows, the better the capabilities of disposable bronchoscopes through digital imaging and miniaturization. High-definition cameras, fiber optics, and advanced visualization systems are now offered in these devices, and physicians can diagnose and intervene more accurately.

Further improvements in procedural efficiency and better patient outcomes are being achieved through the inclusion of features like 3D imaging, augmented reality, and wireless connectivity. The advances further reduce procedural time and the risk of complications, hence becoming more attractive disposable bronchoscopes for use across diverse healthcare settings. Continuously evolving imaging technology ensures that disposable bronchoscopes will represent one of the most important applications in the field of minimally invasive diagnostics and therapy while offering new opportunities in both developed and emerging markets.

Industry Experts Opinion

“We introduced the world’s first flexible single-use bronchoscope 13 years ago, breaking new ground in intensive care units and operating rooms worldwide. However, until now, the advanced needs in the bronchoscopy suite were never met by single-use scopes. Now, we have created a single-use portfolio that meets these needs – one that is on par with reusable bronchoscopes, in some areas even superior.”

•   Bassel Rifai, Chief Marketing Officer, Ambu.

"We'll launch the bronchoscope in the second half of 2021 and we believe this will be a nice $2 billion market for us."

•  Michael Mahoney, CEO, Boston Scientific.

Segment Analysis

Based on the Product Type, the Disposable Bronchoscope Market is classified into Rigid Bronchoscopes, Flexible Bronchoscopes, Adult Disposable Bronchoscopes, Paediatric Disposable Bronchoscopes, and Neonatal Disposable Bronchoscopes. Flexible bronchoscopes are the largest segment of the disposable bronchoscope market, as they are very versatile for use in a wide range of diagnostic and especially therapeutic procedures.

Flexible bronchoscopes offer superior manoeuvrability for complex bronchial structures. Hence, they are highly effective for patients in both adult and pediatric populations. The likelihood of doing minimally invasive procedures such as tissue biopsies, foreign body extractions, and airway ventilation has increased the usage of these devices in medical setups. The acceptance of single-use flexible bronchoscopes is on the rise because they are less likely to cause cross-contamination, thereby adhering to the strictest infection control standards. Technological improvements have enhanced the quality of images and ease of use, thus increasing their demand in the market.

Based on the indication, the disposable bronchoscope market is classified into lung cancer, pulmonary infections, interstitial lung disease, tuberculosis, COPD, cystic fibrosis, and others. The lung cancer segment is the largest in the disposable bronchoscope market because of the very high prevalence and mortality rate of this disease all over the world. Lung cancer patients are usually subjected to multiple bronchoscopic procedures for diagnosis, staging, and treatment and thus require more disposable bronchoscopes.

These devices are used because they do not carry any risks of cross-contamination, especially in immunocompromised patients with cancer. The increase in minimally invasive diagnostic techniques, including bronchoscopy-guided biopsies and visualization of the tumor, supports their use. The technological advancement in disposable bronchoscopes ensures precise imaging and navigation, which makes them indispensable in lung cancer management. With widening awareness and early screening initiatives, this segment remains the most dominant in the market.

Regional Analysis

The North American disposable bronchoscope market is driven primarily by the rising prevalence of respiratory disorders such as COPD, asthma, and lung cancer, as well as an aging population. This market benefits from the region's well-developed healthcare infrastructure, extensive adoption of single-use medical equipment, and stringent infection control legislation.

The United States accounts for the highest market share in this region because of strong R&D initiatives, substantial healthcare expenditure, and favorable reimbursement policies. Canada is another major contributor, with growing awareness and usage of disposable bronchoscopes in outpatient settings. However, it is a cost-intensive and environment-sensitive product that has challenges regarding medical waste. Opportunities are presented by technological advances, eco-friendly product development, and expanding applications in bronchoscopy-guided procedures.

The Asia-Pacific is the fastest-growing region for the disposable bronchoscopes market due to the growing healthcare industry and the availability of awareness of infection control and respiratory diseases. This is especially good for countries like China and India, which enjoy high patient numbers besides improvements in related services such as hospitals. Government plans intending to extend the healthcare facilities and boost investments in medical technologies also have a great role here. In addition, increased procedural volume resulting from increased hospitalization and ASCs, along with technology adoption of minimally invasive procedures, propels the Asia-Pacific market as a lucrative market with strong growth in the future.

Competitive Landscape

The disposable bronchoscope market exhibits intense market competition in terms of product development, product differentiation, and collaborations. Ambu A/S is currently the market leader, offering a range of single-use bronchoscopes that are favored by customers due to their superior image quality and operational simplicity. Likewise, Olympus Corporation has invested heavily in research and innovations to provide cheaper, one-time-use bronchoscopes to suit multiple medical usages. This group also responds that companies like Boston Scientific Corporation have entered the disposable bronchoscope market and have boosted their distribution networks to gain more markers.

International players that are coming into the current competition possess highly innovative and more specialized players in the disposable bronchoscope market. Smith & Nephew identifies itself as a medical company with medical technology expertise to produce highly effective disposable bronchoscopes that meet the safety needs of the patient and ease of use in healthcare facilities with an increasing need for infection control measures.

The NeoScope has received much attention for innovative single-use bronchoscope offerings for purposes of improved image definition and ease of operation. Despite their narrow concentration and cost-cutting orientation, these businesses are establishing themselves with sizable market shares across the board. The global disposable bronchoscope market is expected to see increased competition and improvement as a result of these introductions and ongoing improvements.

Disposable Bronchoscope Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In December 2023, Ambu mentioned that the Centers for Medicare & Medicaid Services (CMS) approved a transitional pass-through (TPT) payment to the company’s ‘aScope 5 Broncho HD’, a single-use bronchoscope. The approval for this device was hoped to spur greater use of endoscopic single-use bronchoscopes across healthcare institutions.
• In April 2023, Verathon launched its latest product, the BFlex 2, which is a second-generation, single-use bronchoscope. The BFlex 2 line was available in four different sizes and designed to introduce new features that can improve the experience of the patients.

Report Coverage:

By Product Type

• Rigid Bronchoscopes
• Flexible Bronchoscopes
• Adult Disposable Bronchoscopes
• Pediatric Disposable Bronchoscopes
• Neonatal Disposable Bronchoscopes

By Indication

• Lung Cancer
• Pulmonary Infections
• Interstitial Lung Disease
• Tuberculosis
• COPD
• Cystic Fibrosis
• Other

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic and Specialty Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Ambu A/S
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Karl Storz GmbH & Co. KG
• NeoScope Inc.
• Olympus Corporation
• PENTAX Medical
• Richard Wolf GmbH
• Stryker Corporation
• Smith & Nephew, Inc.
• Teleflex Incorporated
• Cook Medical
• HOYA Corporation
• Broncus Medical, Inc.
• Advin Health Care
• Novatech SA

Frequently Asked Questions (FAQs)